BEOVU: payments to doctors
Payments that named BEOVU as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $4.2M
- Providers
- 2,338
- Transactions
- 7,765
- Average per transaction
- $541
The per-transaction average — $541 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 2,338 providers the average total is $1,796, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Novartis | $3,538,248 | 84.2% |
| Novartis Pharma AG | $661,522 | 15.8% |